KIMBERLY PHILLIPS: Open Payments
NPI 1265552442 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 64 payments from 14 companies in 2025. Trend: 2023 $201 · 2024 $187 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $590 |
| Janssen Biotech, Inc. | 12 | $255 |
| Amgen Inc. | 1 | $149 |
| Madrigal Pharmaceuticals | 2 | $138 |
| Novo Nordisk Inc | 1 | $125 |
| GENZYME CORPORATION | 4 | $105 |
| PFIZER INC. | 5 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Medtronic, Inc. | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
Products named: RINVOQ, TREMFYA, DUPIXENT, REZDIFFRA, Wegovy, SKYRIZI, CREON, XELJANZ.
Industry payments across MO — which companies pay providers there.
